Description
Connective Tissue Support - InnovaPharm Superior Cissus 180 Capsules
Get down to the core of joint health with InnovaPharm Superior Cissus! Cissus Quadrangularis is know for its benefits in bone and joint health, and InnovaPharm Superior Cissus delivers a potent 4,800 mg of cissus Quadrangularis per daily serving. Protect your joints, boost your bone health, and more with InnovaPharm Superior Cissus!
InnovaPharm Superior Cissus Benefits
- Supports a Healthy Inflammatory Response
- Formulated for Maximum Strength
- Promotes Bone & Joint Health
- Provides Connective Tissue Support
- Formulated for Athletes
How to Take InnovaPharm Superior Cissus
Take as a dietary supplement. Take 3 capsules twice daily with food.
InnovaPharm Superior Cissus Ingredients
Supplement Facts
Serving Size: 6 Capsules
Servings per Container: 30
Amount per Serving %DV
QuadraFlex 4,800mg **
Cissus Quadrangularis (stem) Extract (5% Ketosterones)
**Daily Value not established.
Other ingredients: Gelatin, Magnesium Strearate, Silicon Dioxide, Rice Flour.
InnovaPharm Superior Cissus Warnings
This product is only intended to be consumed by adults 18 years of age or older. Do not use if you are pregnant or nursing. Do not use this product if you have any serious medical conditions. Before using this product, consult with a licensed, qualified health care professional, including but not limited to, if you suspect you have or have been treated for diagnosed with or have a family history of any medical condition, or if you are using any prescription or over the counter medication. Immediately discontinue use and contact a medical doctor if you experience any adverse reaction to this product.
References
Bloomer RJ, Farney TM, McCarthy CG, Lee SR. Cissus quadrangularis reduces joint pain in exercise-trained men: a pilot study. Phys Sportsmed. 2013 Sep;41(3):29-35. doi: 10.3810/psm.2013.09.2021. PMID: 24113700.
https://pubmed.ncbi.nlm.nih.gov/24113700/
Brahmkshatriya HR, Shah KA, Ananthkumar GB, Brahmkshatriya MH. Clinical evaluation of Cissus quadrangularis as osteogenic agent in maxillofacial fracture: A pilot study. Ayu. 2015;36(2):169-173. doi:10.4103/0974-8520.175542
